BlossomHill Therapeutics, Inc. BLSM
IPO
NASDAQ
| 06/30/2026 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.78% | -- | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | -30.32% | -- | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | -15.67% | -- | |||
|
|
|||||
| Total Current Assets | -15.67% | -- | |||
| Net Property, Plant & Equipment | -2.47% | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 0.00% | -- | |||
| Total Assets | -13.44% | -- | |||
|
|
|||||
| Total Accounts Payable | -26.95% | -- | |||
| Total Accrued Expenses | 23.56% | -- | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 133.06% | -- | |||
| Total Finance Division Other Current Liabilities | -- | -- | |||
| Total Other Current Liabilities | -- | -- | |||
| Total Current Liabilities | 15.10% | -- | |||
|
|
|||||
| Total Current Liabilities | 15.10% | -- | |||
| Long-Term Debt | -- | -- | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | -1.36% | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 8.73% | -- | |||
|
|
|||||
| Common Stock & APIC | 28.03% | -- | |||
| Retained Earnings | -15.23% | -- | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | -14.90% | -- | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | 0.00% | -- | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | 0.00% | -- | |||
|
|
|||||
| Total Common Equity | -14.90% | -- | |||
| Total Preferred Equity | 0.00% | -- | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | -21.64% | -- | |||
|
|
|||||